These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35671978)

  • 1. Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance.
    Qadri H; Haseeb Shah A; Ahmad Mir M; Fazal Qureshi M; Prasad R
    Fungal Genet Biol; 2022 Jul; 161():103713. PubMed ID: 35671978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole resistance in a
    Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
    J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Sharma M; Prasad R
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4834-43. PubMed ID: 21768514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile.
    Pinto ACC; Rocha DAS; Moraes DC; Junqueira ML; Ferreira-Pereira A
    An Acad Bras Cienc; 2019 Jul; 91(3):e20180654. PubMed ID: 31365653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CWHM-974 is a fluphenazine derivative with improved antifungal activity against
    Miron-Ocampo A; Beattie SR; Guin S; Conway T; Meyers MJ; Moye-Rowley WS; Krysan DJ
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056723. PubMed ID: 37702508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
    Karababa M; Coste AT; Rognon B; Bille J; Sanglard D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans.
    Shah AH; Singh A; Dhamgaye S; Chauhan N; Vandeputte P; Suneetha KJ; Kaur R; Mukherjee PK; Chandra J; Ghannoum MA; Sanglard D; Goswami SK; Prasad R
    Biochem J; 2014 Jun; 460(2):223-35. PubMed ID: 24621232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3.
    Monod M; Feuermann M; Salamin K; Fratti M; Makino M; Alshahni MM; Makimura K; Yamada T
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
    Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
    FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All about CDR transporters: Past, present, and future.
    Prasad R; Balzi E; Banerjee A; Khandelwal NK
    Yeast; 2019 Apr; 36(4):223-233. PubMed ID: 30192990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1.
    Madani G; Lamping E; Cannon RD
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
    Sanglard D; Ischer F; Monod M; Bille J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals.
    Jaiswal N; Kumar A
    Mol Biotechnol; 2024 May; 66(5):960-974. PubMed ID: 38206530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.